Plain-English translation of NCT07673107 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a new medication called to see if it can help reduce tremors in your hands and arms. Essential tremor makes everyday tasks like writing, eating, and pouring difficult, and this study wants to find out whether this treatment is safe and actually works. You would receive injections over about 18 months, and researchers would track how much your tremor improves.
Many people with hand tremors struggle with simple daily activities, and current treatment options are limited. This medication is being developed to offer a new, potentially effective way to reduce tremors and help people regain control of their hands.
You likely qualify if…
You likely don't qualify if…
You would visit a study clinic at one of about 40 locations across the United States or Canada to receive muscle injections—either the new medication or a placebo (inactive treatment). Half of participants will receive the actual medication and half will receive placebo, decided by random assignment. Over 72 weeks (about 18 months), you'll have follow-up visits where doctors will check how you're doing, ask you questions about your tremor and any side effects, and monitor your overall health.
AI-generated summary from trial data · Aug 28, 2026 · Not medical advice
United States